The Inova Type 2 Diabetes Mellitus Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Diabetes, Type 2
Interventions
DRUG

Glargine

Glargine given as 100% total daily dose with breakfast. The initial dose will be calculated using the patient's weight or using their basal insulin doses prior to hospitalization.

DRUG

NPH

NPH 2/3 of the total daily dose given with breakfast, 1/3 of the total daily dose given at bedtime. The initial dose is calculated using the patient's weight or using the basal insulin dose prior to hospitalization.

Trial Locations (1)

22042

Inova Fairfax Hospital, Falls Church

Sponsors
All Listed Sponsors
lead

Inova Health Care Services

OTHER